Department of Plastic Surgery, Saint Louis Hospital, Avenue Claude-Vellefaux, 75010, Paris, France.
Aesthetic Plast Surg. 2009 Sep;33(5):706-15. doi: 10.1007/s00266-009-9377-1. Epub 2009 Jun 4.
BACKGROUND: Over the last 30 years there has been interest in the use of autologous fat transplantation for breast reconstructive and cosmetic purposes. Up until now injection of adipose tissue into the breast has been subject to two limiting factors. First, fat injection into the breast could result in fat necrosis, cyst formation, and indurations that could be mistaken as cancerous calcifications. Second, the degree of reabsorption of the injected adipose tissue is unpredictable. METHODS: Patients included in the study were candidates for either breast reconstruction after tumor resection or breast augmentation and were divided into three groups. Group I included patients with asymmetry after mastectomy and breast reconstruction; Group II consisted of patients with congenital breast asymmetry; and Group III included patients requesting bilateral breast augmentation. All patients signed a consent form acknowledging potential complications of infiltrating fat into the breast. RESULTS: A total of 820 consecutive female patients were operated on between 1983 and 2007. The age distribution of the patients ranged from 19 to 78 years, with a mean of 45.6 years. There were 381 patients in Group I, 54 in Group II, and 385 in Group III. Complications included ecchymosis in 76 patients, striae in 36 patients, 12 hematomas, and 5 infections. Long-term breast asymmetry was observed in 34 cases. Six hundred seventy patients have undergone mammography and ultrasonography 6 months and 1 year after their first intervention under our care. The majority of complications resulting from lipofilling of the breast have been seen in this series during the first 6 months after each session. Breast lesions, including calcifications, cysts, and cancer, that are not apparent in the first year after the final procedure of lipofilling we believe may not be directly associated with the autologous fat grafting to the breast. This has been confirmed by the long-term follow-up of 230 patients (range = 2-25 years, mean = 11.3 years) who have been followed up yearly with mammographic examination. CONCLUSION: In the last 25 years the results of autologous fat transplantation have been predictable and satisfying on the condition that the treatment is performed in stages with small quantities of adipose tissue fat injected in each treatment session. To prevent major complications the final expected result should not be the aim of a single procedure. Mammary lipografting is a procedure that can be offered to patients for breast reconstructive and cosmetic purposes.
背景:在过去的 30 年中,人们对自体脂肪移植在乳房重建和美容方面的应用产生了兴趣。直到现在,将脂肪组织注射到乳房中一直受到两个限制因素的影响。首先,脂肪注射到乳房中可能导致脂肪坏死、囊肿形成和硬结,这些可能被误认为是癌性钙化。其次,注射的脂肪组织的吸收率是不可预测的。
方法:本研究纳入的患者为肿瘤切除后乳房重建或乳房增大的候选者,并分为三组。I 组包括乳房切除和重建后出现不对称的患者;II 组包括先天性乳房不对称的患者;III 组包括要求双侧乳房增大的患者。所有患者均签署了同意书,承认将脂肪浸润到乳房中可能出现的并发症。
结果:1983 年至 2007 年间,共有 820 例连续女性患者接受了手术。患者年龄分布在 19 岁至 78 岁之间,平均年龄为 45.6 岁。I 组有 381 例患者,II 组有 54 例患者,III 组有 385 例患者。并发症包括 76 例瘀斑、36 例条纹、12 例血肿和 5 例感染。长期乳房不对称在 34 例中观察到。在我们的护理下,670 例患者在第一次干预后 6 个月和 1 年接受了乳房 X 线摄影和超声检查。在每次治疗后的前 6 个月中,我们发现乳房脂肪填充的大多数并发症都发生在这一系列中。在乳房脂肪填充的最后一次手术后 1 年内,我们认为乳房中出现的包括钙化、囊肿和癌症在内的乳腺病变可能与自体脂肪移植到乳房中没有直接关系。对 230 例患者(随访时间= 2-25 年,平均= 11.3 年)进行了长达 25 年的长期随访,每年进行乳房 X 线检查,证实了这一点。
结论:在过去的 25 年中,自体脂肪移植的结果是可以预测的,并且在分阶段进行、每次治疗中注射少量脂肪组织的情况下是令人满意的。为了防止严重的并发症,单一手术不应成为最终预期的结果。乳房脂肪移植是一种可向患者提供乳房重建和美容目的的手术。
Aesthetic Plast Surg. 2009-6-4
Aesthet Surg J. 2013-5
J Plast Reconstr Aesthet Surg. 2008-7
Breast Cancer. 2016-1
Ann Plast Surg. 2011-5
J Gynecol Obstet Biol Reprod (Paris). 2015-6
Aesthet Surg J. 2008
Medicine (Baltimore). 2025-2-28
Research (Wash D C). 2023-5-10
Plast Reconstr Surg Glob Open. 2022-10-28
Aesthetic Plast Surg. 2023-2
World J Stem Cells. 2021-11-26